Company profile

After ten years of technical precipitation, Xiamen hongpufu Biotechnology Co., Ltd. was formally established in 2019. It is a biotechnology company that focuses on the design, development and industrialization of super stable mixed preparations, molecular image probes and vesicle delivery systems, and serves the cause of human life and health.

Focusing on tumor, cardiovascular disease, brain disease, ophthalmic disease and other fields, Amoy Hopeful Biotechnology Co., Ltd. is involved in the research of rheumatoid disease and other aspects, and is the first to create a high-pressure dissolving method to prepare medicine lipiodol solvent--Superstable Homogeneous Iodinated Formulation Technology(SHIFT),Depending on this technology, we can combine the lipiodol used in clinic with the molecule of chemotherapy drug, radiotherapy drug or image probe to prepare the super stable imaging & treatment preparation, the super stable homogeneous pure drug preparation, chemical and biological preparation, and provide technical support and solutions for medical institutions, universities, scientific research institutes and high-tech enterprises to carry out relevant research.

The company has rich R & D experience, and the research results have been published in adv mater, JACS, angel Chem, NAT commun, SCI adv, PNAs and other internationally renowned journals. A kind of super stable fluorescent lipiodol ICG mixed contrast agent prepared by shift technology has been successfully used in the treatment of liver cancer embolism and operation navigation. The project of "industrialization of new iodized oil composite preparation" won the only a + support in the biomedical industry of "Xiamen leading entrepreneurial talents" in 2019.